ONCODESIGN PRECISION MEDICINE S.A. | WebDisclosure

Basculer en Français

9551	Companies
188497	Keywords
120329	Articles
100651	Press releases

Headlines Articles Press releases ONCODESIGN PRECISION MEDICINE S.A.

Home
Companies
ONCODESIGN PRECISION MEDICINE S.A.

PRESS RELEASE

published on 03/05/2025 at 15:52, 9 months 13 days ago

Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors
Oncodesign Precision Medicine appoints Christophe Thurieau, Executive Director Research at Servier, as an independent member of the Board of Directors for a four-year term. Thurieau brings over 35 years of healthcare expertise to OPM

Board Of Directors Healthcare Christophe Thurieau Oncodesign Precision Medicine Servier
BRIEF

published on 03/05/2025 at 15:52, 9 months 13 days ago

Christophe Thurieau rejoint le Conseil d'Administration d'Oncodesign Precision Medicine

Biotechnologie Conseil D'administration Nomination Christophe Thurieau Oncodesign Precision Medicine
BRIEF

published on 03/05/2025 at 15:52, 9 months 13 days ago

Christophe Thurieau joins the Board of Directors of Oncodesign Precision Medicine

Board Of Directors Biotechnology Appointment Christophe Thurieau Oncodesign Precision Medicine
PRESS RELEASE

published on 03/05/2025 at 15:47, 9 months 13 days ago

Nomination of Christophe Thurieau as an Independent Member of OPM Board of Directors
Nomination de Christophe Thurieau en tant qu’administrateur indépendant du Conseil d’Administration d’OPM. Christophe Thurieau, expert en Recherche et Développement Pharmaceutique, rejoindra OPM pour un mandat de 4 ans

Biopharmaceutique Médecine De Précision Administrateur Indépendant OPM Christophe Thurieau
BRIEF

published on 10/15/2024 at 08:05, 1 year 2 months ago

OPM-101 Phase 1 Trial Results Presented at UEG Week 2024

Ulcerative Colitis Phase 1 Trial UEG Week 2024 OPM-101 Safety Profile
BRIEF

published on 10/15/2024 at 08:05, 1 year 2 months ago

Résultats de l'essai de phase 1 OPM-101 présentés à l'UEG Week 2024

Rectocolite Hémorragique Semaine UEG 2024 OPM-101 Essai De Phase 1 Profil De Sécurité
PRESS RELEASE

published on 10/15/2024 at 08:00, 1 year 2 months ago

Inside Information / Other news releases
OPM presents safety & efficacy data on OPM-101, a novel RIPK2 kinase inhibitor, in healthy volunteers at UEG Week 2024 conference, targeting IBD treatment

Precision Medicine UEG Week 2024 OPM-101 RIPK2 Kinase Inhibitor IBD Treatment

Accesswire

Published on 12/18/2025 at 22:45, 22 minutes ago

Stabilis Solutions Announces Multi-Year Marine Bunkering Agreement with Carnival Coprporation at Proposed Galveston LNG Liquefaction Facility
Published on 12/18/2025 at 20:50, 2 hours 17 minutes ago

Results of AGM
Published on 12/18/2025 at 18:00, 5 hours 7 minutes ago

PPX Mining Announces 2025 AGM Results
Published on 12/18/2025 at 15:00, 8 hours 7 minutes ago

Vox Royalty Acquires Feasibilty-Stage Stockman Copper-Gold Royalty in Australia
Published on 12/18/2025 at 14:31, 8 hours 36 minutes ago

Worksport Reports Highest Monthly Revenue in Company History

View all ACCESSWIRE

EQS Group

Published on 12/18/2025 at 22:05, 1 hour 2 minutes ago

Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology
Published on 12/18/2025 at 22:05, 1 hour 2 minutes ago

Abivax to be Added to Nasdaq Biotechnology Index
Published on 12/18/2025 at 20:09, 2 hours 58 minutes ago

EQS-Adhoc: The Grounds Real Estate Development AG: Conversion of the EUR 17 million bond issued in 2023/2024 into a hybrid bond
Published on 12/18/2025 at 19:30, 3 hours 37 minutes ago

Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE EN REPONSE ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES DANS LE CADRE DE L’OFFRE PUBLIQUE DE RETRAIT
Published on 12/18/2025 at 19:30, 3 hours 37 minutes ago

Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES , NOTAMMENT JURIDIQUES, FINANCIERE DE PHAST INVEST

Les Echos

Published on 12/18/2025 at 18:30, 4 hours 37 minutes ago

Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
Published on 12/18/2025 at 18:30, 4 hours 37 minutes ago

Schneider Electric finalise l’opération d’acquisition des 35% restants du capital de sa JV existante en Inde
Published on 12/18/2025 at 17:45, 5 hours 22 minutes ago

Cie du Bois Sauvage: Vernietiging eigen aandelen
Published on 12/18/2025 at 17:45, 5 hours 22 minutes ago

Damartex réaffirme son éligibilité au PEA-PME
Published on 12/18/2025 at 17:45, 5 hours 22 minutes ago

Cie du Bois Sauvage : Cancellation of own shares

View all LES ECHOS COMFI WIRE